Chemokine IP-10 may be a diagnostic or prognostic biomarker (significantly increased in plasma) in ischemic stroke-infection and its specific receptor CXCR3 may be the alternative targets for stroke-infection therapy in the near future. This evidence concerns the gene CXCR3 and infection.